John Kapoor Net Worth

John Kapoor is the founder and former CEO and chairman of Insys Therapeutics, a controversial opioid manufacturer. Born in 1942 in Phoenix, Arizona, Kapoor owns nearly 70% of Insys' shares and was arrested in October 2017 for allegedly conspiring to bribe doctors to needlessly prescribe fentanyl spray Subsys. He denied the charges and resigned as chairman of Akorn, a generic prescription drug maker, in the same month. Insys has been subject to multiple investigations in connection with the marketing and sales of Subsys.
John Kapoor is a member of Healthcare

Age, Biography and Wiki

Birth Year 1942
Birth Place Phoenix, Arizona, United States
Age 81 YEARS OLD
Residence Phoenix, Arizona, US
Alma mater Institute of Chemical Technology, Mumbai SUNY Buffalo
Known for Founder, Akorn Pharmaceuticals Founder and chairman, Insys Therapeutics
Spouse(s) Editha Kapoor (deceased)
Children 4

💰 Net worth: $1.8 Billion (2024)

John Kapoor, a prominent figure in the healthcare industry in the United States, is estimated to have a net worth of $1.8 billion in 2024. With his extensive contributions to the field, Kapoor has successfully garnered substantial wealth over the years. As a renowned figure in the healthcare sector, he has undoubtedly left a significant impact through his work and innovations, making him one of the most influential individuals in the industry.

2014 $2.4 Billion
2015 $3.3 Billion
2016 $2.1 Billion
2017 $1.7 Billion
2018 $1.41 Billion

Some John Kapoor images

Biography/Timeline

1972

He began his career in 1972 at Invenex Pharmaceutical on Grand Island, NY. He worked his way up at LyphoMed.

2017

In October 2017, Kapoor was arrested in Arizona and charged with RICO conspiracy, conspiracy to commit wirefraud, and conspiracy to violate the Anti-Kickback Law. The charges stem from allegations he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, an addictive synthetic opioid. U.S. Attorney william Weinreb said the charges reflected authorities' commitment to combat the opioid epidemic. Kapoor is also alleged to have conspired to defraud health insurance providers. Shortly after the charges were announced, Kapoor resigned from the Board of Insys Therapeutics.